Healthy Skepticism Library item: 13096
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Light DW.
Reply to DiMasi, Hansen, and Grabowski.
J Health Polit Policy Law 2008 Apr; 33:(2):325-7
http://jhppl.dukejournals.org/cgi/reprint/33/2/325?view=long&pmid=18325905
Abstract:
Besides critiquing the Congressional Budget Office for failing to cite and discuss evidence from independent sources that suggest that the net corporate costs of pharmaceutical research and development costs are much lower than industry advocates claim, Light’s review showed how these high estimates are constructed realities that one can reconstruct by using different assumptions, data, or calculations and come up with much lower estimates. In their reply here, DiMasi, Hansen, and Grabowski unwittingly reinforce that point.
